Crossmark Global Holdings’s PLDT PHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$304K Sell
17,359
-456,473
-96% -$8.83M ﹤0.01% 1061
2026
Q1
$9.97M Buy
473,832
+296
+0.1% +$6.69K 0.15% 159
2025
Q4
$10.3M Buy
473,536
+5,214
+1% +$107K 0.15% 153
2025
Q3
$8.76M Sell
468,322
-15,011
-3% -$322K 0.13% 181
2025
Q2
$10.5M Buy
483,333
+213,950
+79% +$4.83M 0.17% 146
2025
Q1
$5.89M Buy
+269,383
New +$6.23M 0.1% 218
2021
Q4
Sell
-12,082
Closed -$394K 1443
2021
Q3
$394K Sell
12,082
-328,492
-96% -$8.91M 0.01% 1042
2021
Q2
$8.95M Buy
+340,574
New +$9.05M 0.21% 121

Other funds holding PHI

Crossmark Global Holdings's PHI Position: Q2 2026 in Review

Crossmark Global Holdings reduced its PLDT (PHI) stake by 96% in Q2 2026, selling an estimated $8.83M and leaving 17,359 shares worth $304K. The position accounts for ﹤0.01% of the portfolio, ranked #1061.

Crossmark Global Holdings first reported a position in PHI in Q2 2021 and has held it in 8 quarters since. The position peaked at $10.5M in Q2 2025. 100 funds tracked by Wall St. Rank hold PHI as of Q2 2026.

  • Crossmark Global Holdings held 17,359 shares of PLDT worth $304K as of Q2 2026.
  • Crossmark Global Holdings sold 456,473 PLDT shares in Q2 2026, an estimated $8.83M.
  • PLDT made up ﹤0.01% of Crossmark Global Holdings's portfolio in Q2 2026, its #1061 holding.
  • Crossmark Global Holdings first reported a position in PLDT in Q2 2021 and has held it in 8 quarters since.
  • Crossmark Global Holdings's PLDT position peaked at $10.5M in Q2 2025.
  • 100 funds tracked by Wall St. Rank held PLDT as of Q2 2026.

Based on Crossmark Global Holdings's 13F filing for Q2 2026, filed 16 Jul 2026.